Nicardipine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nicardipine. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Pedal edema | 7.1% |
| Dizziness | 6.9% |
| Headache | 6.4% |
| Asthenia | 5.8% |
| Flushing | 5.6% |
| Increased angina | 5.6% |
| Palpitations | 3.3% |
| Nausea | 1.9% |
| Dyspepsia | 1.5% |
| Dry mouth | 1.4% |
| Somnolence | 1.4% |
| Rash | 1.2% |
| Tachycardia | 1.2% |
| Myalgia | 1% |
| Other edema | 1% |
| Paresthesia | 1% |
| Sustained tachycardia | 0.8% |
| Syncope | 0.8% |
| Constipation | 0.6% |
| Dyspnea | 0.6% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
I. Stable Angina Nicardipine hydrochloride capsules are indicated for the management of patients with chronic stable angina (effort-associated angina). Nicardipine hydrochloride capsules may be used alone or in combination with beta-blockers. II. Hypertension Nicardipine hydrochloride capsules are indicated for the treatment of hypertension. Nicardipine hydrochloride capsules may be used alone or in combination with other antihypertensive drugs. In administering nicardipine hydrochloride it is important to be aware of the relatively large peak to trough differences in blood pressure effect (See DOSAGE AND ADMINISTRATION ).
Medical disclaimer: Always consult a qualified healthcare professional about any medication.